Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
ENHERTU Trockensub 100 mg Durchstf
Drug
Enhertu, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Brustkrebs, Magenkarzinom
07.16.1. – cytostatics
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
11/29/2021
6/30/2027
Dosage strength
Enhertu 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Brustkrebs, Magenkarzinom
01
Z – approved
Package
7680679670013
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component Freeze-dried preparation
100 mg trastuzumabum deruxtecanum
saccharum
histidinum
histidini hydrochloridum monohydricum
polysorbatum 80
histidinum
histidini hydrochloridum monohydricum
polysorbatum 80
Spezialitätenliste***
SL
-
-
1704.15
None
Yes
10%
No
Authorisation holder
7601001308855
Daiichi Sankyo (Schweiz) AG
Vulkanstrasse 106
8048 Zürich (ZH)
Vulkanstrasse 106
8048 Zürich (ZH)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.